Holen Sie sich die Stockscreener-App
7.42
1.98%
-0.15
Handel nachbörslich:
7.61
0.19
+2.56%
Schlusskurs vom Vortag:
$7.57
Offen:
$7.49
24-Stunden-Volumen:
665.54K
Relative Volume:
2.31
Marktkapitalisierung:
$266.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.75%
1M Leistung:
+32.26%
6M Leistung:
+77.09%
1J Leistung:
-66.13%
1-Tages-Spanne:
$7.09
$7.574
1-Wochen-Bereich:
$7.09
$8.15
52-Wochen-Spanne:
$2.88
$23.85
Bioage Labs Inc Stock (BIOA) Company Profile
Firmenname
Bioage Labs Inc
Sektor
Telefon
510-806-1445
Adresse
5885 HOLLIS STREET, EMERYVILLE
Vergleichen Sie BIOA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
7.42 | 271.38M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
| 2024-12-10 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-09 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-21 | Eingeleitet | Citigroup | Buy |
| 2024-10-21 | Eingeleitet | Jefferies | Buy |
| 2024-10-21 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioage Labs Inc Aktie (BIOA) Neueste Nachrichten
How to use Fibonacci retracement on BioAge Labs Inc.2025 Market Outlook & Stepwise Entry and Exit Trade Signals - newser.com
Is BioAge Labs Inc. stock a buy before product launchesQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - newser.com
Sector ETF performance correlation with BioAge Labs Inc.2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
Is BioAge Labs Inc. stock attractive for long term wealth buildingTrade Analysis Report & Proven Capital Preservation Methods - newser.com
BioAge Labs Stock: Is a Major Breakout Imminent? - AD HOC NEWS
Is BioAge Labs Inc. (Y7G) stock supported by free cash flowBreakout Watch & Verified Technical Trade Signals - newser.com
Using data models to predict BioAge Labs Inc. stock movementJuly 2025 Big Picture & Reliable Entry Point Trade Alerts - newser.com
What candlestick patterns are forming on BioAge Labs Inc.July 2025 Momentum & Safe Investment Capital Preservation Plans - newser.com
Why BioAge Labs Inc. (Y7G) stock stays undervaluedWeekly Trading Summary & Stock Portfolio Risk Management - newser.com
Why BioAge Labs Inc. stock could be next big winner2025 Dividend Review & Fast Momentum Stock Entry Tips - newser.com
Analyzing BioAge Labs Inc. with risk reward ratio chartsGap Down & High Conviction Buy Zone Picks - newser.com
Analyzing drawdowns of BioAge Labs Inc. with statistical toolsTake Profit & Precise Swing Trade Entry Alerts - newser.com
Order flow analysis tools used on BioAge Labs Inc.Stop Loss & Safe Entry Momentum Tips - newser.com
BioAge Labs (BIOA) Competitors and Alternatives 2025 - MarketBeat
Does BioAge Labs Inc. show high probability of reboundJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com
How strong is BioAge Labs Inc. (Y7G) stock earnings growthJuly 2025 Volume & Trade Opportunity Analysis - newser.com
Obesity Drugmaker Escapes Clinical Trial Securities Suit - Law360
BioAge Labs (NASDAQ:BIOA) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
BioAge Beats IPO Investor Lawsuit Over Weight Loss Trial End (1) - Bloomberg Law News
How BioAge Labs Inc. stock compares to growth peers2025 Major Catalysts & AI Powered Buy/Sell Recommendations - newser.com
Automated trading signals detected on BioAge Labs Inc.July 2025 Fed Impact & High Accuracy Investment Signals - newser.com
Can BioAge Labs Inc. stock resist sector downturnsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Published on: 2025-10-30 23:35:20 - newser.com
BioAge Labs, Inc. (NASDAQ:BIOA) Short Interest Update - MarketBeat
Citigroup Maintains BioAge Labs (BIOA) Buy Recommendation - Nasdaq
Bioage Labs (BIOA) Receives Raised Price Target from Citigroup | - GuruFocus
Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026? - AOL.com
Finanzdaten der Bioage Labs Inc-Aktie (BIOA)
Es liegen keine Finanzdaten für Bioage Labs Inc (BIOA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):